Multilateral call for the next human high-impact pandemic

Scope

Participants are invited to submit research and innovation project proposals aiming to provide solutions and preparedness for highly contagious human infectious disease pandemics which inflict a high impact on society.

These can include (but are not limited to):

• Technologies enabling local resilience or self sufficiency
• Medical intervention robotics
• Infection prevention and protection
• Prevention of antibiotic resistance
• Sanitation technology
• Diagnostics and testing
• Therapeutics, vaccines and medicines
• Medical intervention robotics
• Disease-tracking technology
• Smart technologies for critical production and supply chains under lockdown
• Education technologies and digital workplace
• Govtech/Open data and Big Data

Timetable

• Opening of the Call: 15 May 2020
• Deadline for Eureka applications: 15 July 2020-17:00 CEST
• Deadlines for national funding applications: Varies per country
• Funding Decisions: 15 November 2020
• Projects Duration: Up to 36 months
• Projects Result Implementation: Up to 24 months after project completion preference for shorter launches

Eligibility criteria

In order to apply to the present call, the participants must meet the following qualifications:

• The consortium should include at least two organisations independent of each other from two of the participating countries.
• Funding assistance follows each NFB's funding regulations.
• The project participants must express their willingness to cooperate, on a win-win/fair basis in the development of a new product, industrial process or service.
• The product, process or service must be innovative and there must be a technological risk involved.
• The project must have a civilian purpose .
• The project should benefit all involved partners in a well-balanced consortium.
• The project should have an obvious advantage and added value resulting from the technologic cooperation between the participants (e.g. increased knowledge base, commercial leads, access to R&D infrastructure, etc.).
• A signed consortium agreement (CA) for the purpose of a multi-partner collaborative R&D project is mandatory, unless indicated otherwise by relevant NFB. The CA should at least include the execution and governance of the project, ownership and use of know-how and IPR settlements, and commercialisation of the project results. Project start and funding may be conditional to a signed CA having been received and verified by relevant NFBs; see Section 6 and consult your NFB for details.
• The duration of the project may not exceed 36 months.
• Product, service or process implementation or market launch should happen no later than 24 months after project completion.

Any participant whose collaborative R&D&I project is consistent with the aforementioned criteria can apply to the present call in accordance with their national laws, rules, regulations and procedures in effect, on a non-exchange of funds basis, and subject to budgetary availability.

Each participating NFB may apply additional eligibility criteria based on their national regulations. Applicants are strongly advised, prior to submitting the application, to contact their NFB to discuss their project idea, and verify their project’s eligibility.

Participants from other Eureka countries or countries outside of Eureka can also participate, but funding must be secured within the deadlines for the call.

Submission

There are two stages to the submission and assessment process:

Stage 1: Eureka applications

All participants must complete the Eureka project application form online. It must be completed online by 15 July 2020 by 17.00 Central European Summer Time (CEST). The form must be completed in English.

The project consortium is strongly advised to read the form carefully, follow the guidelines and complete all necessary elements in the form as requested. You can contact your Eureka National Project Coordinators to get support in preparing the form (see below for detailed information for each NFB in Section “Funding conditions and rules per NFB”).

Each Eureka application will be evaluated by the national Eureka offices of the countries involved in that application.

Stage 2: National applications

If required by their NFB, project participants will submit a related national funding application – taking into account all relevant national procedures and submission rules. Submission deadlines might differ between the participating NFBs, see Section “Funding conditions and rules per NFB” below for detailed information.

All applications are assessed against the eligibility criteria of the call before being put forward for the national assessments according to the national evaluation criteria.

The national evaluation is based on the general Eureka eligibility criteria, national eligibility criteria and evaluations, the Eureka application form with annexes, and if required a national application form.

Successful projects are put forward for a Eureka label. After a common list of labeled and non-labeled projects has been agreed, applicants will be informed about the results.

Funding details

Funding will only be provided to projects that are positively evaluated by all relevant participating NFBs. Funding of project participants is subjected to budgetary availability and national funding conditions stipulated by each NFB. See the attached documents for more information. 

The NFB will provide access to public investment for the selected projects. The support will be given to each participant by its respective NFB in accordance with their national laws, rules, regulations and procedures in effect, on a non-exchange of funds or soft loan basis, and subject to budgetary availability for each NFB. 

Submit your application

Downloadables